LEADER 02252nam 2200613 450 001 9910463363703321 005 20211022032142.0 010 $a3-11-135864-X 024 7 $a10.1515/9783111358642 035 $a(CKB)3390000000035734 035 $a(EBL)3043108 035 $a(OCoLC)894510130 035 $a(SSID)ssj0001051988 035 $a(PQKBManifestationID)11573079 035 $a(PQKBTitleCode)TC0001051988 035 $a(PQKBWorkID)11075082 035 $a(PQKB)11028718 035 $a(MiAaPQ)EBC3043108 035 $a(DE-B1597)64963 035 $a(OCoLC)979813041 035 $a(DE-B1597)9783111358642 035 $a(Au-PeEL)EBL3043108 035 $a(CaPaEBR)ebr10760119 035 $a(EXLCZ)993390000000035734 100 $a20140813h19691969 uy 0 101 0 $aeng 135 $aur||#|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe development of the proto-Indo-European laryngeals in Greek /$fR. S. P. Beekes 205 $aReprint 2012 210 1$aThe Hague, Netherlands :$cMouton,$d1969. 210 4$d©1969 215 $a1 online resource (348 p.) 225 1 $aJanua Linguarum. Series Practica ;$v42 300 $aIncludes index. 311 0 $a3-11-100147-4 327 $tFront matter --$tPREFACE --$tTABLE OF CONTENTS --$tBIBLIOGRAPHY --$tABBREVIATIONS AND SYMBOLS --$tINTRODUCTION --$tINTRODUCTION --$tTHE GREEK MATERIAL --$tLARYNGEAL AT THE BEGINNING OF THE WORD --$tLARYNGEAL AT THE END OF THE WORD --$tLARYNGEAL IN THE MIDDLE OF THE WORD --$tDIALECTAL DIFFERENCES --$tCONCLUSIONS --$tAPPENDICES --$tADDENDA --$tINDICES 410 0$aJanua linguarum. Series practica ;$v42. 606 $aProto-Indo-European language$xPhonology 606 $aIndo-European languages$xPhonology 608 $aElectronic books. 615 0$aProto-Indo-European language$xPhonology. 615 0$aIndo-European languages$xPhonology. 676 $a481/.5 700 $aBeekes$b R. S. P$g(Robert Stephen Paul),$0219315 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910463363703321 996 $aDevelopment of the proto-indo-european laryngeals in greek$9572865 997 $aUNINA LEADER 04487nam 22003973 450 001 9910510571003321 005 20211130080204.0 010 $a9783030867058$b(electronic bk.) 010 $z9783030867041 035 $a(MiAaPQ)EBC6816987 035 $a(Au-PeEL)EBL6816987 035 $a(CKB)19934882800041 035 $a(OCoLC)1287130205 035 $a(EXLCZ)9919934882800041 100 $a20211130d2022 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFeatures and Management of Acute and Chronic Neuro-Covid 210 1$aCham :$cSpringer International Publishing AG,$d2022. 210 4$d©2022. 215 $a1 online resource (172 pages) 311 08$aPrint version: Cascella, Marco Features and Management of Acute and Chronic Neuro-Covid Cham : Springer International Publishing AG,c2022 9783030867041 327 $aIntro -- Foreword -- Preface -- Acknowledgments -- Contents -- Abbreviations -- 1: Pathophysiology of COVID-19-Associated Neurotoxicity -- 1.1 Introduction -- 1.2 Overview on Neurological Manifestations -- 1.3 Pathophysiology of COVID-19-Associated Neurotoxicity -- 1.3.1 The Issue of SARS-CoV-2 Neurotropism -- 1.3.1.1 The Evidence for SARS-CoV-2 in Nerve Tissue -- 1.3.1.2 Pathogenesis of Direct SARS-CoV-2 Damage -- 1.3.1.3 The Ligand-Receptor Interaction and "Postreceptorial Mechanisms" in Nervous Tissue -- 1.3.2 Mechanisms of Diffusion Towards the Nervous Tissue -- 1.3.2.1 The Hematogenous Route -- 1.3.2.2 The Neurogenic Pathway -- 1.3.2.3 Other Possible Routes -- 1.3.3 Immune-Mediated Neurological Processes -- 1.3.3.1 Cytokine Storm -- 1.3.3.2 Microglial Activation and Blood-Brain Barrier Damage -- 1.3.4 Gut-Brain Axis Involvement -- 1.3.5 Effects of Multiorgan Dysfunction -- 1.4 Potential Mechanisms for Long-Term Neurotoxicity -- 1.5 Pain and COVID-19: The COVID-Pain Issue -- 1.5.1 Acute Clinical Manifestations -- 1.5.2 Long-Term Painful Clinical Manifestations -- 1.6 Ongoing Clinical Research -- 1.7 Research Perspectives -- 1.8 Conclusions -- References -- 2: Acute Manifestations of Neuro-COVID -- 2.1 Introduction. Overview on Clinical Manifestations of the Disease -- 2.2 Pathogenic Mechanisms -- 2.3 Classification Approaches -- 2.4 Central Nervous System Manifestations -- 2.4.1 Headache and Dizziness -- 2.4.2 Acute Encephalopathy -- 2.4.3 Posterior Reversible Encephalopathy Syndrome -- 2.4.4 Seizures -- 2.4.5 Acute Cerebrovascular Diseases -- 2.4.6 Meningitis and Encephalitis -- 2.4.7 Acute Myelitis -- 2.5 PNS Manifestations -- 2.5.1 Hypo/Anosmia and Dysgeusia/Ageusia -- 2.5.2 Guillain-Barré Syndrome and Variants -- 2.5.3 Pain -- 2.6 Skeletal Muscle Manifestations -- 2.6.1 Asthenia and Myalgia. 327 $a2.6.2 Skeletal Muscle Injury -- 2.7 Psychiatric Manifestations -- 2.8 Conclusions -- References -- 3: Diagnostic Approaches to Acute Neuro-COVID -- 3.1 Introduction -- 3.2 Neuroimaging -- 3.2.1 Stroke -- 3.2.2 Cerebral Hemorrhagic Lesions -- 3.2.3 Mixed Pictures -- 3.2.4 Posterior Reversible Encephalopathy Syndrome -- 3.2.5 Encephalitis -- 3.2.6 Myelitis -- 3.2.7 Peripheral Nervous System and Muscular Disorders -- 3.2.8 Clinical and Neuroimaging Correlation -- 3.2.9 The Role of Brain Positron Emission Tomography -- 3.2.10 Other Diagnostic Approaches -- 3.3 Electrodiagnostic Tests -- 3.3.1 EEG: Indications, Approaches, Features, and Limitations -- 3.3.2 ICU-Acquired Weakness in COVID-19 Patients -- 3.3.3 Mixed CNS/PNS Pictures -- 3.4 Laboratory Tests -- 3.5 Neuropathological Findings -- 3.6 Conclusions -- References -- 4: Neurological, Psychological, and Cognitive Manifestations of Long-COVID -- 4.1 Introduction -- 4.2 The Long-COVID Phenomenon in Numbers -- 4.3 Neurological Symptoms -- 4.3.1 Mechanisms -- 4.3.2 Clinical Features -- 4.4 Psychological Sequelae of Long-COVID -- 4.4.1 Disease-Related or Pandemic-Induced Effects? -- 4.4.2 From Acute to Chronic Psychiatric Problems -- 4.5 Potential Long-Term Cognitive Issues -- 4.6 Conclusions -- References. 608 $aElectronic books. 700 $aCascella$b Marco$01062882 701 $aDe Blasio$b Elvio$01068613 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 912 $a9910510571003321 996 $aFeatures and Management of Acute and Chronic Neuro-Covid$92553544 997 $aUNINA LEADER 02084nam2 22004813i 450 001 TO00325448 005 20251003044404.0 010 $a8815047271 100 $a19941024d1994 ||||0itac50 ba 101 | $aita$cita 102 $ait 181 1$6z01$ai $bxxxe 182 1$6z01$an 183 1$6z01$anc$2RDAcarrier 200 1 $aˆLa ‰finanza pubblica italiana$erapporto 1994$fa cura di Luigi Bernardi$gscritti di Luigi Bernardi ... [et al.] 210 $aBologna$cIl mulino$d[1994] 215 $a343 p.$d22 cm. 461 1$1001MIL0221746$12001 $aˆLa ‰finanza pubblica italiana$erapporto ...$fa cura di Luigi Bernardi 500 11$aˆLa ‰finanza pubblica italiana.$3UBS0013785$957615 606 $aITALIA$xFINANZA$x1993-1994$2FIR$3MILC067785$9I 606 $aITALIA$xEconomia$x1994$2FIR$3RAVC064060$9I 676 $a336.01245$9ECONOMIA. Finanza pubblica a livello nazionale. Italia$v23 676 $a336.45$9Finanza pubblica. Italia$v12 676 $a336.45$9FINANZA PUBBLICA IN ITALIA$v20 676 $a336.45$9FINANZA PUBBLICA. Italia$v21 676 $a336.450929$9$v20 696 $aAttività finanziarie$aIndustria finanziaria$aEconomia finanziaria 696 $aEconomia reale$aAttività economiche$aAspetti economici 699 $aFinanza$zAttività finanziarie 699 $aFinanza$yIndustria finanziaria 699 $aFinanza$yEconomia finanziaria 699 $aEconomia$yEconomia reale 699 $aEconomia$zAttività economiche 699 $aEconomia$zAspetti economici 702 1$aBernardi$b, Luigi$f <1946- >$3CFIV083162 801 3$aIT$bIT-000000$c19941024 850 $aIT-BN0095 $aIT-AV0045 901 $bNAP MV$cF $nDEPOSITO LIBRARIO SCIENZE SOCIALI SALA F 912 $aTO00325448 950 2$aBiblioteca Centralizzata di Ateneo$c1993-1998;2000$d 01POZZO LIB.F. PARRAVICINI 637$e 0101 0600175165E VMA (1994 1 v. (Precedente collocazione P. 1659)$fB $h20050930$i20231121 977 $a 01$a MV 996 $aFinanza pubblica italiana$957615 997 $aUNISANNIO